Who We Are

Dr Rosalie Cull is a power networker with multiple business interests in Australia/New Zealand and internationally. She is Managing Director of TudorRose Consulting Pty Ltd and a former Non-Executive Director of ARCS Ltd, as well as being a foundation member of the New Zealand Biotechnology Association.

A protein chemist by training, Dr Cull has a PhD in Biochemistry from La Trobe University, Melbourne and is also a graduate member of the Australian Institute of Company Directors.

Dr Cull has been involved in the successful development and commercialization of prescription medicines, novel delivery systems and devices for over 30 years and has worked for a host of well-known and innovative, Australian, US, European, and NZ companies including: Acrux DDS Pty Ltd, Kendle Australia, CSL, Faulding Pharmaceuticals Biotech Australia, Massey University (New Zealand) and Alapharm (New Zealand).

Deb Cooper has extensive experience in consulting roles, both in Australia and internationally. She has spent a large proportion of her career in multinational innovator companies in Australia and the UK and in senior project management roles in Australian and international consultancies.

Deb also spent more than 5 years leading the regulatory affairs, medical devices and pharmacovigilance divisions within ARCS Australia Ltd, the Australian industry association for professionals in the therapeutic goods development industry.

Deb has proven project management skills; a very broad local and international industry network; and extensive experience working in close collaboration with government; in combination with an appreciation of commercial drivers.

Deb holds a BSc(Hons) in Industrial Chemistry and a Graduate Diploma in Drug Development, both from the University of New South Wales. She also has a Certificate IV in Training and Assessment and is currently completing a Diploma of Project Management with the Australian Institute of Management, formalising her many years of project management experience.